FLORALI
2015
High-Flow Nasal Oxygen versus NIV in Acute Hypoxaemic Failure
In 310 patients with acute non-hypercapnic hypoxaemic respiratory failure, high-flow nasal oxygen improved 90-day mortality compared with standard oxygen or NIV.
Result
Primary endpoint: Intubation rate at 28 days
Intubation similar overall; 90-d mortality HR 2.01 for standard O₂ vs HFNO (p=0.046) and 2.50 for NIV vs HFNO (p=0.006).
- Subtopic
- Oxygenation strategy
- Design
- Multicentre RCT
- Relevance
- Important: one of several pillars.
- Source
- Frat JP, et al. N Engl J Med. 2015;372(23):2185-2196.doi 10.1056/NEJMoa1503326
Discussion & critique
HFNO is now first-line for acute hypoxaemic failure outside hypercapnia.